Actavis buying Warner Chilcott in $8.5B deal
Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.
Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.
Business
May 20, 2013
0
0
Discovery of the new enzyme, available for manufacturing of cis-4-Hydroxy-L-proline, a material of pharmaceutical and cosmetic products.
Biochemistry
May 18, 2011
0
0
Chemicals pervade our lives. While the benefits to society from the development of these chemicals have been impressive, enabling safer, more efficient and more convenient consumer products and life-saving pharmaceuticals, ...
Environment
Nov 9, 2010
0
0
(AP) -- Google, Yahoo and other Web companies joined the pharmaceutical industry Thursday in urging federal regulators to make it easier to pitch drugs in online advertisements.
Internet
Nov 12, 2009
0
0